课题基金 / 基金详情

MAGSCREW ACUTATOR FOR VAD AND TAH PUMPS--PHASE II

MAGSCREW ACUTATOR FOR VAD AND TAH PUMPS--PHASE II
用于 VAD 和 TAH 泵的磁力螺杆执行器 - 第二阶段
批准号:
2771526
负责人:
NICHOLAS G VITALE
金额:
$33.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-06-15 至 2000-08-15

项目摘要

项目成果

NICHOLAS G VITALE的其他基金

相关文献

中文摘要
翻译
在美国国立卫生研究院的第一阶段SBIR资助下,
英文摘要
Under a Phase I SBIR grant from the National Institutes Of Health, Mechanical Technology Incorporated (MTl) has successfully demonstrated the technology of an innovative magnetic Screw (magscrew) actuator for possible use in a total artificial heart (TAH) developed by the Cleveland Clinic Foundation (CCf). Accordingly, this Phase II application describes a joint MTI/CCF program to advance the magscrew actuator design to the level of a fully Integrated TAH subsystem. Additionally, four TAH systems will be built to support both in vitro and in vivo testing. Despite great progress in the prevention and treatment of heart disease, cardiac failure remains the leading cause of death in the United States. Many additional patients are Incapacitated by low cardiac output. In 1991, the Institute of Medicine published a report strongly endorsing continued work on artificial heart research. lt is this social need and commercial opportunity that the MTI/CCF team will address with a next-generation actuator adaptable to both heart assist and heart replacement devices. The ultimate goal of this research is to obtain FDA approval to use the CCF/MTI TAH for investigational clinical trials, and to subsequently gain full regulatory approval to make it available as a clinical product. PROPOSED COMMERCIAL APPLICATIONS The magscrew actuator will be an enabling subsystem (in terms of commercially acceptable life and reliability) for both ventricular assist devices (VADs) and the permanent implantable TAH. According to a 1991 report published by the Institute Of Medicine, there could be 35,000 to 70,000 primary candidates annually for mechanical Circulatory support systems (MCSSs) by year 2010. While most would require VADs, as many as 10,000 to 20,000 cases may justify the use of a TAH. By year 2020, there may be as many as 200,000 secondary candidates for MCSSs. These estimates assume that at least one approved VAD is available by 1999, and that at least one approved TAH 15 available in the early 2000s
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Stent Lock Mechanism for Transcutaneous Catheters
  • 批准号:
    6787974
  • 项目类别:
  • 资助金额:
    $13.94万
  • 财政年份:
    2005
  • 负责人:
    NICHOLAS G VITALE
  • 依托单位:
Compact Membraneless Device for Hemodialysis
  • 批准号:
    6992464
  • 项目类别:
  • 资助金额:
    $29.71万
  • 财政年份:
    2005
  • 负责人:
    NICHOLAS G VITALE
  • 依托单位:
Gas Exchange Array for Implantable Artificial Lung
  • 批准号:
    7053198
  • 项目类别:
  • 资助金额:
    $24.11万
  • 财政年份:
    2004
  • 负责人:
    NICHOLAS G VITALE
  • 依托单位:
MINIATURE ACTUATOR FOR BONE LENGTHENING/TRANSPORT SYSTEM
  • 批准号:
    6210136
  • 项目类别:
  • 资助金额:
    $16.66万
  • 财政年份:
    2000
  • 负责人:
    NICHOLAS G VITALE
  • 依托单位: